Ann Arbor firm gets FDA nod for new medical tool to predict patient ‘crash’
ANN ARBOR—The Ann Arbor clinical analytics startup Fifth Eye Inc. announced that the U.S. Food and Drug Administration has granted its “de novo” classification to Fifth Eye’s Analytic for Hemodynamic …